pubmed-article:3124819 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:3124819 | lifeskim:mentions | umls-concept:C0007090 | lld:lifeskim |
pubmed-article:3124819 | lifeskim:mentions | umls-concept:C0027651 | lld:lifeskim |
pubmed-article:3124819 | lifeskim:mentions | umls-concept:C0034721 | lld:lifeskim |
pubmed-article:3124819 | lifeskim:mentions | umls-concept:C0034693 | lld:lifeskim |
pubmed-article:3124819 | lifeskim:mentions | umls-concept:C0023884 | lld:lifeskim |
pubmed-article:3124819 | lifeskim:mentions | umls-concept:C0035696 | lld:lifeskim |
pubmed-article:3124819 | lifeskim:mentions | umls-concept:C0441889 | lld:lifeskim |
pubmed-article:3124819 | lifeskim:mentions | umls-concept:C0439659 | lld:lifeskim |
pubmed-article:3124819 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
pubmed-article:3124819 | lifeskim:mentions | umls-concept:C1707520 | lld:lifeskim |
pubmed-article:3124819 | lifeskim:mentions | umls-concept:C0750502 | lld:lifeskim |
pubmed-article:3124819 | lifeskim:mentions | umls-concept:C0205250 | lld:lifeskim |
pubmed-article:3124819 | lifeskim:mentions | umls-concept:C0702240 | lld:lifeskim |
pubmed-article:3124819 | lifeskim:mentions | umls-concept:C0443252 | lld:lifeskim |
pubmed-article:3124819 | lifeskim:mentions | umls-concept:C2697585 | lld:lifeskim |
pubmed-article:3124819 | lifeskim:mentions | umls-concept:C0017833 | lld:lifeskim |
pubmed-article:3124819 | pubmed:issue | 1 | lld:pubmed |
pubmed-article:3124819 | pubmed:dateCreated | 1988-3-24 | lld:pubmed |
pubmed-article:3124819 | pubmed:abstractText | We have investigated levels of transcript homologous with glutathione S-transferase P (GST-P; GST 7-7) in tumours and hyperplastic lesions induced in the livers of rats by long-term gavage dosing with diethylnitrosamine (DEN) and 6-p-dimethylaminophenylazobenzothiazole (6BT). Detailed histopathological examination of the livers of the 90 animals used in this study at 6-8 months after initiation of daily dosing revealed that, of the 30 animals treated with carcinogen, 15 had developed tumours or hyperplastic lesions. Of these, 11 were areas of fibrosarcoma/fibrous hyperplasia. The remaining four were hepatocellular carcinomas. Northern blotting of total RNA purified from these tissues revealed the presence of transcripts of 3 and 0.75 kb. Evidence is presented to indicate that the former is a hitherto-undetected precursor of the 3-kbp rat GST-P gene, the latter representing the previously characterized mature GST-P transcript. Large elevations of the 0.75-kb transcript (30-35-fold) were encountered in all of the hepatocellular carcinomas, but in none of the other lesions, indicating a highly significant correlation (P = less than 0.001) between high elevations in levels of GST-P mRNA and liver tumours of hepatocellular origin. Minor elevations in transcript level (less than or equal to 5-fold) were encountered in several of the non-hepatocellular lesions. In regenerating livers, small increases in the level of the 3-kb transcript (approximately 3-fold) were routinely detected in total RNA from all partial hepatectomies, a concomitant decrease of approximately similar magnitude occurring in the 0.75-kb transcript, suggesting that minor elevations in levels of GST-P transcript, where encountered in non-hepatocellular lesions, are related to pre-neoplasia rather than to the proliferative rate of hyperplastic cells per se. The data extend previous observations, carried out largely using short-term regimes, to an analysis of transcripts homologous with GST-P in hyperplastic, pre-neoplastic and neoplastic lesions induced by long-term dosing with genotoxic carcinogens, and strongly lend support to the concept that high (30-fold) elevations in GST-P transcript correlate most strikingly with tumours of hepatocellular origin. | lld:pubmed |
pubmed-article:3124819 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3124819 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3124819 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3124819 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3124819 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3124819 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3124819 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3124819 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3124819 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3124819 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3124819 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3124819 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3124819 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3124819 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3124819 | pubmed:language | eng | lld:pubmed |
pubmed-article:3124819 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3124819 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:3124819 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3124819 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3124819 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3124819 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3124819 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3124819 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3124819 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3124819 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3124819 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3124819 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:3124819 | pubmed:month | Jan | lld:pubmed |
pubmed-article:3124819 | pubmed:issn | 0264-6021 | lld:pubmed |
pubmed-article:3124819 | pubmed:author | pubmed-author:KellyMM | lld:pubmed |
pubmed-article:3124819 | pubmed:author | pubmed-author:HumphriesPP | lld:pubmed |
pubmed-article:3124819 | pubmed:author | pubmed-author:PearsonCC | lld:pubmed |
pubmed-article:3124819 | pubmed:author | pubmed-author:RussellS ESE | lld:pubmed |
pubmed-article:3124819 | pubmed:author | pubmed-author:McQuaidSS | lld:pubmed |
pubmed-article:3124819 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:3124819 | pubmed:day | 1 | lld:pubmed |
pubmed-article:3124819 | pubmed:volume | 249 | lld:pubmed |
pubmed-article:3124819 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:3124819 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:3124819 | pubmed:pagination | 105-9 | lld:pubmed |
pubmed-article:3124819 | pubmed:dateRevised | 2009-11-18 | lld:pubmed |
pubmed-article:3124819 | pubmed:meshHeading | pubmed-meshheading:3124819-... | lld:pubmed |
pubmed-article:3124819 | pubmed:meshHeading | pubmed-meshheading:3124819-... | lld:pubmed |
pubmed-article:3124819 | pubmed:meshHeading | pubmed-meshheading:3124819-... | lld:pubmed |
pubmed-article:3124819 | pubmed:meshHeading | pubmed-meshheading:3124819-... | lld:pubmed |
pubmed-article:3124819 | pubmed:meshHeading | pubmed-meshheading:3124819-... | lld:pubmed |
pubmed-article:3124819 | pubmed:meshHeading | pubmed-meshheading:3124819-... | lld:pubmed |
pubmed-article:3124819 | pubmed:meshHeading | pubmed-meshheading:3124819-... | lld:pubmed |
pubmed-article:3124819 | pubmed:meshHeading | pubmed-meshheading:3124819-... | lld:pubmed |
pubmed-article:3124819 | pubmed:meshHeading | pubmed-meshheading:3124819-... | lld:pubmed |
pubmed-article:3124819 | pubmed:meshHeading | pubmed-meshheading:3124819-... | lld:pubmed |
pubmed-article:3124819 | pubmed:meshHeading | pubmed-meshheading:3124819-... | lld:pubmed |
pubmed-article:3124819 | pubmed:meshHeading | pubmed-meshheading:3124819-... | lld:pubmed |
pubmed-article:3124819 | pubmed:meshHeading | pubmed-meshheading:3124819-... | lld:pubmed |
pubmed-article:3124819 | pubmed:year | 1988 | lld:pubmed |
pubmed-article:3124819 | pubmed:articleTitle | Long-term dosing studies using mutagenic carcinogens indicate a highly significant correlation between elevations in the level of rat glutathione S-transferase P messenger RNA and liver tumours of hepatocellular origin. | lld:pubmed |
pubmed-article:3124819 | pubmed:affiliation | Department of Genetics, Trinity College, Dublin, Ireland. | lld:pubmed |
pubmed-article:3124819 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:3124819 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3124819 | lld:pubmed |